Back to top Open menu arrow
Purchase PDF

Save Save

Cite Cite

Reprints
Sections
CASE VIGNETTE DISCUSSION CONCLUSION Clinical Points
Primary Care Companion for CNS Disorders Primary Care Companion for CNS Disorders

The Primary
Care Companionfor CNS Disorders
Access icon

Rounds in the General Hospital May 11, 2023

Drug-Induced Abnormal Involuntary Movements: Prevalence and Treatment

; ; ; ; ;

Prim Care Companion CNS Disord 2023;25(3):22f03305

LESSONS LEARNED AT THE INTERFACE OF MEDICINE AND PSYCHIATRY

The Psychiatric Consultation Service at Massachusetts General Hospital sees medical and surgical inpatients with comorbid psychiatric symptoms and conditions. During their twice-weekly rounds, Dr Stern and other members of the Consultation Service discuss diagnosis and management of hospitalized patients with complex medical or surgical problems who also demonstrate psychiatric symptoms or conditions. These discussions have given rise to rounds reports that will prove useful for clinicians practicing at the interface of medicine and psychiatry.

  1. Kaufman DM, Geyer HL, Milstein MJ. Involuntary movement disorders. In: Kaufman’s Clinical Neurology for Psychiatrists. 2017:389–447. doi:10.1016/b978-0-323-41559-0.00018-6
  2. Peckham EL, Hallett M. Psychogenic movement disorders. Neurol Clin. 2009;27(3):801–819, vii. PubMed CrossRef
  3. Waln O, Jankovic J. An update on tardive dyskinesia: from phenomenology to treatment. Tremor Other Hyperkinet Mov (N Y). 2013;3:tre-03-161-4138-1. PubMed CrossRef
  4. Sanger TD, Chen D, Fehlings DL, et al. Definition and classification of hyperkinetic movements in childhood. Mov Disord. 2010;25(11):1538–1549. PubMed CrossRef
  5. Ueda K, Black KJ. A comprehensive review of tic disorders in children. J Clin Med. 2021;10(11):2479. PubMed CrossRef
  6. Kojovic M, Cordivari C, Bhatia K. Myoclonic disorders: a practical approach for diagnosis and treatment. Ther Adv Neurol Disord. 2011;4(1):47–62. PubMed CrossRef
  7. D’Souza RS, Hooten WM. Extrapyramidal symptoms. In: StatPearls [Internet]. Treasure Island, Florida: StatPearls Publishing; 2022.
  8. Shin HW, Chung SJ. Drug-induced parkinsonism. J Clin Neurol. 2012;8(1):15–21. PubMed CrossRef
  9. Jinnah HA, Factor SA. Diagnosis and treatment of dystonia. Neurol Clin. 2015;33(1):77–100. PubMed CrossRef
  10. Jhunjhunwala K, Netravathi M, Pal PK. Movement disorders of probable infectious origin. Ann Indian Acad Neurol. 2014;17(3):292–297. PubMed CrossRef
  11. Baizabal-Carvallo JF, Cardoso F. Chorea in children: etiology, diagnostic approach and management. J Neural Transm (Vienna). 2020;127(10):1323–1342. PubMed CrossRef
  12. Voss RM, Das JM. Mental status examination. In: StatPearls [Internet]. Treasure Island, Florida: StatPearls Publishing; 2021.
  13. Benjamin S, Lauterbach MD. The neurological examination adapted for neuropsychiatry. CNS Spectr. 2018;23(3):219–227. PubMed CrossRef
  14. Flaherty AW, Ivkovic A. Movement disorders. In: Stern TA, Fava M, Wilens TE, et al, eds. Massachusetts General Hospital Comprehensive Clinical Psychiatry. 2nd ed. London: Elsevier; 2016.
  15. Espay AJ. Neurologic complications of electrolyte disturbances and acid-base balance. Handb Clin Neurol. 2014;119:365–382. PubMed CrossRef
  16. Rao AR, Kumar P, Gunasekaran V, et al. Reversible chorea secondary to uremia in an older adult. Aging Med (Milton). 2019;2(2):118–120. PubMed CrossRef
  17. Mulroy E, Baschieri F, Magrinelli F, et al. Movement disorders and liver disease. Mov Disord Clin Pract (Hoboken). 2021;8(6):828–842. PubMed CrossRef
  18. Delhasse S, Debove I, Arnold-Kunz G, et al. Erratic movement disorders disclosing Graves’ disease and paralleling thyroid function but not autoantibody levels. J Int Med Res. 2019;47(3):1378–1386. PubMed CrossRef
  19. Freudenreich O, Flaherty AW. Patients with abnormal movements. In: Stern TA, Freudenreich O, Smith FA, et al, eds. Massachusetts General Hospital Handbook of General Hospital Psychiatry. 7th ed. London: Elsevier; 2018.
  20. Bhidayasiri R, Truong DD. Chorea and related disorders. Postgrad Med J. 2004;80(947):527–534. PubMed CrossRef
  21. Burgunder JM. Recent advances in the management of choreas. Ther Adv Neurol Disord. 2013;6(2):117–127. PubMed CrossRef
  22. Gibson JS, Claassen DO. State-of-the-art pharmacological approaches to reduce chorea in Huntington’s disease. Expert Opin Pharmacother. 2021;22(8):1015–1024. PubMed CrossRef
  23. Termsarasab P, Thammongkolchai T, Frucht SJ. Medical treatment of dystonia. J Clin Mov Disord. 2016;3(1):19. PubMed CrossRef
  24. Swain JE, Scahill L, Lombroso PJ, et al. Tourette syndrome and tic disorders: a decade of progress. J Am Acad Child Adolesc Psychiatry. 2007;46(8):947–968. PubMed CrossRef
  25. Katherine M. Stereotypic movement disorders. Semin Pediatr Neurol. 2018;25:19–24. PubMed CrossRef
  26. Sheehey PH, Wells JC. Using response interruption and redirection to reduce vocal stereotypy. Interv Sch Clin. 2018;53(3):171–176. CrossRef
  27. Levy A, Chen R. Myoclonus: pathophysiology and treatment options. Curr Treat Options Neurol. 2016;18(5):21. PubMed CrossRef
  28. Zareifopoulos N, Katsaraki M, Stratos P, et al. Pathophysiology and management of akathisia 70 years after the introduction of the chlorpromazine, the first antipsychotic. Eur Rev Med Pharmacol Sci. 2021;25(14):4746–4756. PubMed
  29. Blaisdell GD. Akathisia: a comprehensive review and treatment summary. Pharmacopsychiatry. 1994;27(4):139–146. PubMed CrossRef
  30. Stahl SM, Sy S, Maguire GA. How and when to treat the most common adverse effects of antipsychotics: Expert review from research to clinical practice. Acta Psychiatr Scand. 2021;143(2):172–180. PubMed CrossRef
  31. Miller F. Spasticity, Spasticity, dystonia, and athetosis management in the upper extremity in cerebral palsy. In: Miller F, Bachrach S, Lennon N, et al, eds. Cerebral Palsy. Cham: Springer; 2020.
  32. Armstrong MJ, Okun MS. Diagnosis and treatment of parkinson disease: a review. JAMA. 2020;323(6):548–560. PubMed CrossRef
  33. Bhidayasiri R, Jitkritsadakul O, Friedman JH, et al. Updating the recommendations for treatment of tardive syndromes: a systematic review of new evidence and practical treatment algorithm. J Neurol Sci. 2018;389:67–75. PubMed CrossRef
  34. Freudenreich O, Goff D, Henderson DC. Antipsychotic drugs. In: Stern TA, Fava M, Wilens TE, et al, eds. Massachusetts General Hospital Comprehensive Clinical Psychiatry. 2nd ed. London: Elsevier; 2016:475–488.e6.
  35. Thippaiah SM, Fargason RE, Birur B. Switching antipsychotics: a guide to dose equivalents. Curr Psychiatr. 2021;20(4):13. CrossRef
  36. Burn DJ, Rowan EN, Minett T, et al. Extrapyramidal features in Parkinson’s disease with and without dementia and dementia with Lewy bodies: a cross-sectional comparative study. Mov Disord. 2003;18(8):884–889. PubMed CrossRef
  37. Tsolaki M, Kokarida K, Iakovidou V, et al. Extrapyramidal symptoms and signs in Alzheimer’s disease: prevalence and correlation with the first symptom. Am J Alzheimers Dis Other Demen. 2001;16(5):268–278. PubMed CrossRef
  38. Peralta V, Cuesta MJ. Motor abnormalities: from neurodevelopmental to neurodegenerative through “functional” (neuro)psychiatric disorders. Schizophr Bull. 2017;43(5):956–971. PubMed CrossRef

About the Authors

Buy PDF for $40

Please sign in or purchase this PDF for $40.

Save Save

Cite Cite

Vol 27 • 2025 • Number 3

Read the Current Issue

Original Research

Conflict Mediation by CBT

Systematic Review

Psychiatric Adverse Effects of Hydroxychloroquine

Review Article

Efficacy of GLP-1 Agonists in Mental Disorders

Rounds in the General Hospital

Time-Limited Teaching of Psychiatry to Medical Students

Rounds in the General Hospital

Multimodal Approaches to Pain Management

Rounds in the General Hospital

Sequelae of Adverse Childhood Experiences
View current Issue

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe